Infectious Agent Surveillance Report
IASR Vol.42
2021/1～(No.491～)
IASR Vol.42, No.6(No.496) June 2021
Pertussis in Japan, as at January 2021
IASR Vol.42, No.5(No.495) May 2021
Enterohemorrhagic Escherichia coli (EHEC) infection as of March 2021 in Japan
IASR Vol.42, No.4(No.494) April 2021
Adenovirus infections, 2008 to 2020, Japan
IASR Vol.42, No.3(No.493) March 2021
Multidrug-Resistant Acinetobacter Infection
IASR Vol.42, No.2(No.492) February 2021
COVID-19 as at December 2020
IASR Vol.42, No.1(No.491) January 2021
Acute hepatitis C, April 2006-October 2020IASR Vol.41
2020/1～(No.479～)
IASR Vol.41, No.12(No.490) December 2020
Exanthema subitum 2000-2020
IASR Vol.41, No.11(No.489) November 2020
Influenza 2019/20 season, Japan
IASR Vol.41, No.10(No.488) October 2020
HIV/AIDS in Japan, 2019
IASR Vol.41, No.9(No.487) September 2020
Rubella and congenital rubella syndrome in Japan as at July 2020
IASR Vol.41, No.8(No.486) August 2020
Japanese spotted fever 1999-2019
IASR Vol.41, No.7(No.485) July 2020
COVID-19 as of May 2020
IASR Vol.41, No.6(No.484) June 2020
Dengue fever and dengue hemorrhagic fever, 2015-2019
IASR Vol.41, No.5(No.483) May 2020
Enterohemorrhagic Escherichia coli (EHEC) infection as of March 2020 in Japan
IASR Vol.41, No.4(No.482) April 2020
Measles in Japan, as of February 2020
IASR Vol.41, No.3(No.481 )March 2020
Clostridioides difficile infection in Japan
IASR Vol.41, No.2(No.480) February 2020
Acute Flaccid Paralysis in Japan as of December 2019
IASR Vol.41, Vo.1(No.479) January 2020
Syphilis, Japan |
|
